SBIO vs XBI

ALPS Medical Breakthroughs ETF against State Street SPDR S&P Biotech ETF: cost, size, returns, what they hold and how much of it is the same.

Overlap by weight
22%
44 shared positions
Fee gap
15 bp
XBI is cheaper
1-year return gap
11.2 pts
XBI is ahead
Larger fund
XBI
$9.9B

Side by side

SBIOXBI
FundALPS Medical Breakthroughs ETFState Street SPDR S&P Biotech ETF
IssuerALPSState Street SPDR
CategoryBiotech & Health InnovationBiotech & Health Innovation
Expense ratio0.50%0.35%
Assets$200M$9.9B
Average daily dollar volume$2.6M$1.4B
ListedDec 30, 2014Jan 31, 2006
FrenzyCap score5796
1-month return−13.7%−1.9%
3-month return−15.8%−1.0%
Year to date+7.5%+26.1%
1-year return+34.6%+45.8%
30-day volatility28.1%27.0%
Worst drawdown, 1 year−23.8%−11.9%
Trailing 12-month yield—0.35%
Holdings89166
Top 10 weight34.8%16.9%
Look-through P/E——
Holdings vs fair value+12.5%+5.8%
Holdings above 200-day average43%62%
Net flow, latest 3 reported months+$17M thru May 2026+$1.3B thru Jun 2026
30-day implied volatility37.3%31.2%
Holdings as ofas of May 31, 2026SEC filingas of Oct 8, 2026issuer data

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

65% of SBIO · 22% of XBI
HoldingSBIOXBI
SYRE3.68%1.39%
ALKS4.48%1.34%
ORKA1.80%1.28%
KYMR4.24%1.20%
TVTX2.77%1.19%
DNTH2.63%1.17%
MIRM3.90%1.03%
CGON3.35%1.00%
VKTX2.41%0.98%
RLAY1.60%0.87%
CELC3.92%0.83%
IDYA1.65%0.59%
DNLI2.13%0.59%
VERA1.61%0.56%
AGIO1.10%0.56%
SRPT1.20%0.55%
NVAX1.14%0.52%
ACAD2.35%0.50%
PVLA1.03%0.49%
CLDX1.33%0.48%
VCEL1.08%0.45%
IRON1.69%0.45%
MLYS1.59%0.34%
XNCR0.56%0.33%
STOK1.13%0.32%

Sector mix of the stock holdings

SectorSBIOXBIGap
Health Care100.0%99.2%+0.9%
Financials0.0%0.7%−0.7%

More: full overlap table · SBIO holdings · XBI holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.